Subscribe to Newsletter

Discovery & Development


Discovery & Development Advanced Medicine

Victor Ambros and Gary Ruvkun share 2024 Nobel Prize for Physiology or Medicine

| Rob Coker

The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation

Discovery & Development Dosage Forms

Dosage Form Innovation with Hot Melt Extrusion

| 3 min read

We look at three recent studies that demonstrate the versatility of hot melt extrusion for developing patient-centric dosage forms.

Discovery & Development Drug Discovery

Cell Wars: A New Hope

| Rob Coker

Researchers use AI to reprogram glioblastoma cancer cells

Discovery & Development Formulation

The Liquid Challenge

| Louise Carpenter | 4 min read

Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.

Discovery & Development Clinical Trials

Clinical Trials and Digital Doubles

| 5 min read

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

Discovery & Development Translational Science

Of Mice and Monkeys

| Rob Coker | 3 min read

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

Discovery & Development Drug Discovery

Let’s Make a Real Difference in Cancer

| 7 min read

We interview Lars Erwig, Director of the Centre of Drug Development at Cancer Research UK, about his career.

Discovery & Development Clinical Trials

Inhibitors Versus Diabetes … And Dementia!

| Rob Coker

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

Discovery & Development Drug Delivery

Mini Magnetic Medics

| Rob Coker

Nanorobots developed by engineers from the UK and China have delivered precision treatment to brain aneurysms

Discovery & Development Drug Discovery

Boosting Naloxone’s Effectiveness Against Opioid Overdoses

| Jamie Irvine

A recent US-based study discovered a new compound that could enhance naloxone’s ability to fend off more potent opioids.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register